Ethics, pricing and the pharmaceutical industry

This paper explores the ethical obligations of pharmaceutical companies to charge fair prices for essential medicines. The moral issue at stake here is distributive justice. Rawls' framework is especially germane since it underlines the material benefits everyone deserves as Kantian persons and...

Full description

Saved in:  
Bibliographic Details
Main Author: Spinello, Richard A. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Springer Science + Business Media B. V 1992
In: Journal of business ethics
Year: 1992, Volume: 11, Issue: 8, Pages: 617-626
Further subjects:B Health Care
B Pharmaceutical Company
B Pharmaceutical Industry
B Critical Factor
B Economic Growth
Online Access: Volltext (JSTOR)
Volltext (lizenzpflichtig)

MARC

LEADER 00000caa a22000002 4500
001 1785603256
003 DE-627
005 20230427062125.0
007 cr uuu---uuuuu
008 220112s1992 xx |||||o 00| ||eng c
024 7 |a 10.1007/BF00872273  |2 doi 
035 |a (DE-627)1785603256 
035 |a (DE-599)KXP1785603256 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Spinello, Richard A.  |e VerfasserIn  |4 aut 
245 1 0 |a Ethics, pricing and the pharmaceutical industry 
264 1 |c 1992 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a This paper explores the ethical obligations of pharmaceutical companies to charge fair prices for essential medicines. The moral issue at stake here is distributive justice. Rawls' framework is especially germane since it underlines the material benefits everyone deserves as Kantian persons and the need for an egalitarian approach for the distribution of society's essential commodities such as health care. This concern for distributive justice should be a critical factor in the equation of variables used to set prices for pharmaceuticals. 
601 |a Industrie 
650 4 |a Pharmaceutical Company 
650 4 |a Pharmaceutical Industry 
650 4 |a Critical Factor 
650 4 |a Economic Growth 
650 4 |a Health Care 
773 0 8 |i Enthalten in  |t Journal of business ethics  |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1982  |g 11(1992), 8, Seite 617-626  |h Online-Ressource  |w (DE-627)270937129  |w (DE-600)1478688-6  |w (DE-576)121465284  |x 1573-0697  |7 nnns 
773 1 8 |g volume:11  |g year:1992  |g number:8  |g pages:617-626 
856 |3 Volltext  |u http://www.jstor.org/stable/25072314  |x JSTOR 
856 4 0 |u https://doi.org/10.1007/BF00872273  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
935 |a mteo 
936 u w |d 11  |j 1992  |e 8  |h 617-626 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 403366212X 
LOK |0 003 DE-627 
LOK |0 004 1785603256 
LOK |0 005 20220112043447 
LOK |0 008 220112||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2021-12-31#3BDE46C00FDAAEE16B562A110F2D4ADCADA242D2 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/25072314 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
ORI |a SA-MARC-ixtheoa001.raw